The respiratory microbiota alpha-diversity in chronic lung diseases: first systematic review and meta-analysis
Open Access
- 23 August 2022
- journal article
- review article
- Published by Springer Nature in Respiratory Research
- Vol. 23 (1) , 1-15
Abstract
Background: While there seems to be a consensus that a decrease in gut microbiome diversity is related to a decline in health status, the associations between respiratory microbiome diversity and chronic lung disease remain a matter of debate. We provide a systematic review and meta-analysis of studies examining lung microbiota alpha-diversity in patients with asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF) or bronchiectasis (NCFB), in which a control group based on disease status or healthy subjects is provided for comparison. Results: We reviewed 351 articles on title and abstract, of which 27 met our inclusion criteria for systematic review. Data from 24 of these studies were used in the meta-analysis. We observed a trend that CF patients have a less diverse respiratory microbiota than healthy individuals. However, substantial heterogeneity was present and detailed using random-effects models, which limits the comparison between studies. Conclusions: Knowledge on respiratory microbiota is under construction, and for the moment, it seems that alpha-diversity measurements are not enough documented to fully understand the link between microbiota and health, excepted in CF context which represents the most studied chronic respiratory disease with consistent published data to link alpha-diversity and lung function. Whether differences in respiratory microbiota profiles have an impact on chronic respiratory disease symptoms and/or evolution deserves further exploration.Keywords
Funding Information
- Université de Bordeaux
- Institut National de la Santé et de la Recherche Médicale
- Institut national de recherche en informatique et en automatique
This publication has 66 references indexed in Scilit:
- The Effects of Airway Microbiome on Corticosteroid Responsiveness in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Changes in Cystic Fibrosis Airway Microbiota at Pulmonary ExacerbationAnnals of the American Thoracic Society, 2013
- Asthma-associated differences in microbial composition of induced sputumJournal of Allergy and Clinical Immunology, 2013
- The Lung Microbiome in Moderate and Severe Chronic Obstructive Pulmonary DiseasePLOS ONE, 2012
- Prevalence of Streptococci and Increased Polymicrobial Diversity Associated with Cystic Fibrosis Patient StabilityJournal of Bacteriology, 2012
- Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPDPLOS ONE, 2011
- Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis IndividualsPLOS ONE, 2009
- Heterogeneity testing in meta‐analysis of genome searchesGenetic Epidemiology, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000